Mycobacterium Kansasii disease presenting as a lung mass and bronchial anthracofibrosis

Tuberculosis and Respiratory Diseases

Volumn 60, Issue 4, 2006, Pages 464-468

  Ra, Seung Won ^a   Lee, Kwang Ha ^a   Jung, Ju Young ^a   Kang, Ho Suk ^a   Park, I Nae ^a   Choi, Hye Sook ^a   Jung, Hoon ^a   Chon, Gyu Rak ^a   Shim, Tae Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Anthracofibrosis; Lung mass; Mycobacterium kansasii

Indexed keywords

ARTHRITIS; ARTICLE; BRONCHOSCOPY; CELL INFILTRATION; CELLULITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EMPHYSEMA; HUMAN; INCIDENCE; KOREA; LUNG CAVITY; LUNG CYST; LUNG FIBROSIS; LUNG INFECTION; LUNG LOBE; LYMPHADENITIS; MEDICAL ASSESSMENT; MYCOBACTERIUM KANSASII; OSTEOMYELITIS; PROBABILITY; THORAX RADIOGRAPHY; TUBERCULOSIS; ULCER;

EID: 33746402333     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2006.60.4.464     Document Type: Article

References (14)

1. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25.
2. Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci 2005;20:957-60.
3. Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med 2002;23:613-21.
4. Koh WJ, Kwon CJ, Suh GY, Chung MP, Kim HJ, Lee NY, et al. A case report of three patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium kansasii. Tuberc Respir Dis 2003;54:459-66.
5. Scientific Committee in Korean Academy of Tuberculosis and Respiratory Diseases. National survey of mycobacterial diseases other than tuberculosis in Korea. Tuberc Respir Dis 1995;42:277-94.
6. Maliwan N, Zvetina JR. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience. Postgrad Med J 2005;81:530-3.
7. Aberg JA, Yajko DM, Jacobson MA. Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. J Infect Dis 1998;178:1446-9.
8. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.
9. Park SY, Paris JH, Jegal YJ, Lee JH, Lim CM, Lee SD, et al. A case of idiopathic CD4+ T-lymphocytopenia with disseminated Mycobacterium kansasii infection and pulmonary alvelolar proteinosis. Tuberc Respir Dis 2000;48:377-82.
10. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998;129:698-704.
11. Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160:15-21.
12. Ahn CH, Lowell JR, Ahn SS, Ahn S, Hurst GA. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. Rev Infect Dis 1981;3:1028-34.
13. Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace FM, Greer DL, et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995;21:77-85.
14. Manali ED, Tomford WJ, liao DW, Farver C, Mehta AC. Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient. Respiration 2005;72:305-8.